In addition to patients with PTSD, the study will also include patients who suffer from other mental disorders such as depressions or anxiety disorders, given that they have experienced a traumatic life event and as a result suffer from relevant feelings of guilt and shame (see in- and exclusion criteria). F43.1
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: -Experience of a traumatic event that meets the trauma criterion according to DSM-5 (American Psychiatric Association, 2013) - Strong feelings of guilt and shame related to this event (defined via cut-offs of the TRGI and TRSI and the exploration during the CAPS-5 interview) - Presence of a clinical mental disorder according to DSM-5 (American Psychiatric Association, 2013) - Sufficient knowledge of German - Willingness to participate regularly in the treatemnt sessions and to practice the exercises taught in the sessions at home - Written consent to participate in the study
Exclusion criteria
Exclusion criteria: - Parallel psychotherapeutic treatment - Substance abuse or dependence within the last 3 months - suicide attempt or life-threatening self-harm within the last 6 months - Lifetime diagnosis of schizophrenia, schizoaffective disorder, or bipolar affective disorder - Body mass index <17.5 - Organic mental disorders - Severe physical or mental limitations that obstruct participation in longer meditation practices
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Questionnaire based data/self-report: - Trauma-Related Guilt Inventory (Kubany et al., 1996) to asses trauma-related feelings of guilt - Trauma-Related Shame Inventory (TRSI; Øktedalen, Hagtvet, Hoffart, Langkaas, & Smucker, 2014) to assess trauma-related feelings of shame - Shame and Guilt Trauma Scale (SGATS; Aakvaag et al., 2014) as a short instrument to measure trauma-related feelings of shame and guilt --> pre assessment, two intermediate assessments after session 3 and 6, post assessment (after finishing the intervention and a 4 week practice period) Diagnostic interview: Clinician Administered PTSD Scale for DSM-5 (CAPS-5; Weathers et al., 2017) to assess PTSD symptoms during the last 4 weeks in a clinical interview --> pre and post assessment | — |
Secondary
| Measure | Time frame |
|---|---|
| Questionnaire based data/self-report: - Posttraumatic Cognition Inventory (PTCI; Foa, Ehlers, Clark, Tolin & Orsillo, 1999) to assess trauma-related cognitions - Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5; Blevins, Weathers, Davis, Witte, & Domino, 2015) to assess PTSD symptoms during the last 4 weeks - Beck Depression Inventory II (BDI-II; Hautzinger, Keller, & Kühner, 2006) to assess depressive symptoms during the past 2 weeks - Brief Symptom Inventory (BSI; Franke, 2000) to assess the subjective impairment caused by physical and psychological symptoms during the past week - WHO-Five Well-Being Index (WHO-5; Bech, Olsen, Kjoller, & Rasmussen, 2003) to assess well-being during the past 2 weeks - Self-Compassion Scale (SCS; Neff, 2003) to measure self-compassion --> pre and post assessment Diagnostic interview: - pre assessment: Structured Clinical Interview for DSM-5 (SCID-5-CV; First, Williams, Karg, & Spitzer, 2015) - post assessment: Only the relevant sections of SCID-5-CV in which the symptoms for a mental disorder were fulfilled in the initial diagnostic session | — |
Countries
Germany
Contacts
Goethe-Universität, Institut für Psychologie Klinische Psychologie und Psychotherapie